Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
暂无分享,去创建一个
E. J. Brown | L A Moyé | B R Davis | T E Cuddy | G. Lamas | B. Davis | M. Pfeffer | J. Rouleau | E. Braunwald | M. Packer | G. Flaker | L. Moyé | J. Rutherford | S. Goldman | E. Geltman | C. M. Hawkins | S Goldman | E Braunwald | M A Pfeffer | L. Basta | T. Cuddy | E J Brown | G C Flaker | L Basta | E M Geltman | J. Wertheimer | M. Klein | J. Rouleau | L. Moye | E. Brown | C. Hawkins
[1] M. Pfeffer,et al. Left Ventricular Diastolic Pressure‐Volume Relations in Rats with Healed Myocardial Infarction: Effects on Systolic Function , 1981, Circulation research.
[2] J. Ritchie,et al. Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial. , 1986, Circulation.
[3] E. Gilpin,et al. Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction. , 1986, The American journal of cardiology.
[4] M. Pfeffer,et al. Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.
[5] M. Pfeffer,et al. Rationale, design and baseline characteristics of the survival and ventricular enlargement trial , 1991 .
[6] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[7] E. Gilpin,et al. A decision scheme for coronary angiography after acute myocardial infarction. , 1989, Circulation.
[8] K. Hammermeister,et al. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. , 1979, Circulation.
[9] J. Fleiss,et al. Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.
[10] J. S. Janicki,et al. Cardiac myocyte necrosis induced by angiotensin II. , 1991, Circulation research.
[11] J. B. Garrison,et al. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. , 1979, The New England journal of medicine.
[12] F. Klocke,et al. Guidelines for the early management of patients with acute myocardial infarction , 1990 .
[13] W Grossman,et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. , 1986, Circulation.
[14] P Smith,et al. The effect of warfarin on mortality and reinfarction after myocardial infarction. , 1990, The New England journal of medicine.
[15] G. Lamas,et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. , 1988, The New England journal of medicine.
[16] R M Whitlock,et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.
[17] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[18] M. Pfeffer,et al. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. , 1985, Circulation.
[19] W. Kannel. Epidemiology and prevention of cardiac failure: Framingham Study insights. , 1987, European heart journal.
[20] D. Roden,et al. Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study). , 1989, The American journal of cardiology.
[21] R. Virmani,et al. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion. , 1992, Journal of the American College of Cardiology.
[22] W. Kannel,et al. Prognosis after initial myocardial infarction: the Framingham study. , 1979, The American journal of cardiology.
[23] G. Lamas,et al. Activation of neurohumoral systems following acute myocardial infarction. , 1991, The American journal of cardiology.
[24] A. Moss,et al. Prognosis and management after a first myocardial infarction. , 1990, The New England journal of medicine.
[25] R. Jeremy,et al. Patterns of left ventricular dilation during the six months after myocardial infarction. , 1989, Journal of the American College of Cardiology.
[26] J. Fleiss,et al. Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. The Multicenter Diltiazem Post-Infarction Research Group. , 1990, Journal of the American College of Cardiology.
[27] G. Ertl,et al. Early remodelling of the left ventricle in patients with myocardial infarction. , 1990, European heart journal.
[28] M. Pfeffer,et al. Influence of Chronic Captopril Therapy on the Infarcted Left Ventricle of the Rat , 1985, Circulation research.
[29] J. Laragh,et al. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. , 1991, The New England journal of medicine.
[30] N. Sharpe,et al. TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION , 1988, The Lancet.
[31] F. Tristani,et al. Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .
[32] J. Giudicelli,et al. Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat. , 1987, The American journal of cardiology.